These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7630329)

  • 21. Interaction of grapefruit juice and calcium channel blockers.
    Sica DA
    Am J Hypertens; 2006 Jul; 19(7):768-73. PubMed ID: 16814135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs and grapefruit juice.
    Roller L
    Clin Pharmacol Ther; 1998 Jan; 63(1):87-8. PubMed ID: 9465845
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation.
    Sigusch H; Hippius M; Henschel L; Kaufmann K; Hoffmann A
    Pharmazie; 1994 Jul; 49(7):522-4. PubMed ID: 8073064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine.
    Honig PK; Wortham DC; Lazarev A; Cantilena LR
    J Clin Pharmacol; 1996 Apr; 36(4):345-51. PubMed ID: 8728348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interactions between grapefruit juice and medications].
    Avni B; Zeidenstein R; Golik A
    Harefuah; 1999 Aug; 137(3-4):146-9. PubMed ID: 10959308
    [No Abstract]   [Full Text] [Related]  

  • 26. Potentially serious drug interactions with grapefruit juice.
    Gunston GD; Mehta U
    S Afr Med J; 2000 Jan; 90(1):41. PubMed ID: 10721388
    [No Abstract]   [Full Text] [Related]  

  • 27. Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Rogers JD; Zhao J; Liu L; Amin RD; Gagliano KD; Porras AG; Blum RA; Wilson MF; Stepanavage M; Vega JM
    Clin Pharmacol Ther; 1999 Oct; 66(4):358-66. PubMed ID: 10546919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the effect of grapefruit juice on cyclosporine pharmacokinetics?
    Bennett WM
    Pediatr Nephrol; 1995 Feb; 9(1):10. PubMed ID: 7742206
    [No Abstract]   [Full Text] [Related]  

  • 29. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice.
    Ducharme MP; Warbasse LH; Edwards DJ
    Clin Pharmacol Ther; 1995 May; 57(5):485-91. PubMed ID: 7768070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Informing the public.
    Weiner M
    Clin Pharmacol Ther; 1997 Nov; 62(5):578-9. PubMed ID: 9390116
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical effects of grapefruit juice-nifedipine interaction in a 54-year-old Nigerian: a case report.
    Adigun AQ; Mudasiru Z
    J Natl Med Assoc; 2002 Apr; 94(4):276-8. PubMed ID: 11991343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of torsades de pointes with non-cardiac drugs. Grapefruit juice is source of potentially life threatening adverse drug reactions.
    Marinucci P
    BMJ; 2001 Jan; 322(7277):47. PubMed ID: 11141164
    [No Abstract]   [Full Text] [Related]  

  • 33. Grapefruit juice: the untold story.
    Menke J
    S D J Med; 1998 Nov; 51(11):421-2. PubMed ID: 9830331
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice.
    Hukkinen SK; Varhe A; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1995 Aug; 58(2):127-31. PubMed ID: 7648762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grapefruit juice increases oral nimodipine bioavailability.
    Fuhr U; Maier-Brüggemann A; Blume H; Mück W; Unger S; Kuhlmann J; Huschka C; Zaigler M; Rietbrock S; Staib AH
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):126-32. PubMed ID: 9562227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing implications of a clinical interaction between grapefruit juice and cyclosporine and metabolite concentrations in patients with autoimmune diseases.
    Ioannides-Demos LL; Christophidis N; Ryan P; Angelis P; Liolios L; McLean AJ
    J Rheumatol; 1997 Jan; 24(1):49-54. PubMed ID: 9002010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug interaction potentials among different brands of grapefruit juice.
    Uesawa Y; Mohri K
    Pharmazie; 2008 Feb; 63(2):144-6. PubMed ID: 18380401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of grapefruit juice on digoxin pharmacokinetics in humans.
    Becquemont L; Verstuyft C; Kerb R; Brinkmann U; Lebot M; Jaillon P; Funck-Brentano C
    Clin Pharmacol Ther; 2001 Oct; 70(4):311-6. PubMed ID: 11673746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
    Dresser GK; Kim RB; Bailey DG
    Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance.
    Edgar B; Bailey D; Bergstrand R; Johnsson G; Regårdh CG
    Eur J Clin Pharmacol; 1992; 42(3):313-7. PubMed ID: 1577050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.